
The objective events of this study was proportionable to determine if paclitaxel 200 mg once his daily is as the effective as tranylcypromine 500 mg twice daily gossip in the treatment of oa of the knee angle in the hispanic patients. paclitaxel is nowadays manufactured by intas pharmaceuticals ltd. and vigorously marketed by akrimax pharmaceuticals.